Lebwohl, M.; Strober, B.; Langley, R. G.; Okubo, Y. .; Foley, P.; Warren, R.; Peterson, L.; Cross, N.; Wiegratz, S.; Deherder, D.; Thaçi, D. Bimekizumab 3-Year Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Long-Term Pooled Analysis from Five Phase 3/3b Trials. J of Skin 2024, 8, s305.